0000899243-22-012858.txt : 20220330 0000899243-22-012858.hdr.sgml : 20220330 20220330203352 ACCESSION NUMBER: 0000899243-22-012858 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220330 FILED AS OF DATE: 20220330 DATE AS OF CHANGE: 20220330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aivado Manuel CENTRAL INDEX KEY: 0001709603 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 22788677 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 285 SUMMER STREET STREET 2: UNIT 101 CITY: BOSTON STATE: MA ZIP: 02210 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-03-30 2022-03-24 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001709603 Aivado Manuel C/O AILERON THERAPEUTICS, INC. 285 SUMMER STREET, SUITE 101 BOSTON MA 02210 1 1 0 0 See Remarks Stock Option (right to buy) 0.48 2022-03-30 4 A 0 1133000 0.00 A 2032-03-29 Common Stock 1133000 1133000 D This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026. President and Chief Executive Officer /s/ Richard Wanstall, attorney in fact for Manuel Aivado 2022-03-30